Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 1999Annals of Neurology

Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis

View Full Paper
Ask AI
Bookmark
Share

Authors

ABAnette H.H. van Boxel-DezaireCleveland Clinic Lerner College of MedicineSHSabine HoffBayer (Germany)BOBob W. van OostenAmsterdam Neuroscience

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Boxel-Dezaire et al. (1999) studied this question.

synapsesocial.com/papers/6a6f7d4f26a7f98052dc2485https://doi.org/10.1002/1531-8249(199906)45:6<695::aid-ana3>3.0.co;2-r
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1An Interleukin (IL)-10/IL-12 Immunoregulatory Circuit Controls Susceptibility to Autoimmune Disease1998 · 473 citations
  2. 2Increased Production of Tumor Necrosis Factor α, and Not of Interferon γ, Preceding Disease Activity in Patients With Multiple Sclerosis1998 · 63 citations
  3. 3Increased interleukin 12 production in progressive multiple sclerosis: Induction by activated CD4<sup>+</sup>T cells via CD40 ligand1997 · 323 citations